Melanoma in Practice: Nurse Conference
26 July 2018
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’. Designed specifically for nurses, the presentations were designed to give nurses a better understanding of the patient experience from detection through to treatment of advanced disease and included updates in the latest areas of research that are changing the way we treat melanoma.
Presentations were given by melanoma specialists in dermatology, pathology, medical oncology, surgery, radiotherapy, physiotherapy, psychology and clinical trials, as well as melanoma survivors and CNCs who are directly involved in melanoma care
Highlights included a presentation from Associate Professor Robyn Saw who discussed the processes of surgical management of melanoma Stages 0-IV and how “understanding the anatomy is essential for diagnosing and treating melanoma”.
A key takeaway from the conference was a presentation by Associate Professor Matteo Carlino. Associate Professor Carlino delved into the system therapy for the treatment of advanced melanoma and notably pointed out how there has been a shift in nurses’ role in melanoma. “It used to be that advanced melanoma nurses worked primarily on palliative care. We're now in a time where nurses are working on survivorship care”, said Associate Professor Carlino, a statement that really resonated with the audience.
We’d like to thank those who attended and engaged with the conference. One attendee said that ‘all the sessions were so informative and the presenters had a real passion for their work’ and we hope that all attendees found it both enjoyable and beneficial.
The presentations from the Nurse Conference will be made available on our free melanoma education portal for healthcare practitioners in the next few weeks. If you’re a nurse, we encourage you to register your interest at www.melanomaeducation.org.au to be the first to know when they become available.
Research from MIA is changing the way melanoma is managed worldwide and improving patient survival. Here are a few of our key highlights from this year.
A prestigious Fellowship has been awarded to fund research that will change the way melanoma treatment is assessed in the future.
New research from MIA has been published that forms the basis of the updated international guidelines for staging melanoma.
Professor William McCarthy AM has been awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care.
Leading researchers from MIA have been acknowledged with three prestigious awards for excellence in melanoma research.
New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
2018 will be bigger than ever, and a little bit different.
MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.
Congratulations to our Conjoint Medical Directors, Professor Georgina Long and Professor Richard Scolyer, who have today been announced as Fellows of the Australian Academy of Health and Medical Sciences.
New research shows potentially deadly UV damage can appear decades earlier than you think.
Early lymph node check is saving lives in melanoma patients
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?
In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.